Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Specifically, vitamin D and folate levels were higher in the poor-outcome group, whereas vitamin E, vitamin A, vitamin K1, vitamin B12, and homocysteine also differed significantly between groups.
Source: Outcome grouping and univariable comparisons. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Other blinding reported · Human research reported
Reported blinded roles: assessors.
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This single-center retrospective cohort study consecutively included 655 patients with acute ischemic stroke (AIS) admitted to Huludao Central Hospital between November 2024 and July 2025.
Source: Methods.
All patients were admitted within 24 h after symptom onset.
Source: Methods.
Whenever feasible, outcome assessors were blinded to baseline vitamin measurements to reduce information bias.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
A vitamin-biomarker risk score for 90-day functional outcome after acute ischemic stroke: development and internal validation in a retrospective cohort
Cohort study · Frontiers in Neurology · 2026
Original publication title
A vitamin-biomarker risk score for 90-day functional outcome after acute ischemic stroke: development and internal validation in a retrospective cohort
Copyright © 2026 Xu, He, Kang, Liu and Xu.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
The prognostic value of vitamin-related biomarkers in acute ischemic stroke (AIS) remains incompletely defined. This study evaluated associations between serum vitamin-related markers and 3-month functional outcome and developed an internally validated nomogram for individualized risk prediction.
Source: BackgroundAbstract: What methods does the paper describe?
Consecutive AIS patients admitted to Huludao Central Hospital between November 2024 and July 2025 were retrospectively included (n = 655). The analyzed sample included 342 men (52.2%) and 313 women (47.8%), with a mean age of 66.84 ± 9.85 years and a mean admission NIHSS score of 3.98 ± 4.35. Poor outcome was defined as a 3-month modified Rankin Scale (mRS) score of 3 to 6, and good outcome as mRS ≤ 2. Demographic and clinical characteristics, routine laboratory indices, and serum levels of vitamin D, vitamin E, vitamin A, vitamin K1, vitamin B12, folate, and homocysteine were collected.
Candidate variables were screened by univariable analyses and entered into multivariable logistic regression. Multivariable analyses adjusted for age, sex, BMI, admission NIHSS score, infarct location, vascular risk factors, atrial fibrillation, coronary heart disease, moderate-to-severe arterial stenosis, serum albumin, and total protein. A nomogram was constructed using the rms package in R. Internal validation was performed with 1,000 bootstrap resamples. Discrimination, calibration, and clinical net benefit were assessed using receiver operating characteristic curves, calibration curves, and decision curve analysis.
Source: MethodsAbstract: Results
Among 655 patients, 346 (52.82%) had poor outcomes and 309 (47.18%) had good outcomes at 3 months. Multivariable analysis identified vitamin D, vitamin E, vitamin A, vitamin K1, vitamin B12, folate, and homocysteine as independent predictors of poor outcome. The nomogram showed good discrimination, with an AUC of 0.878 in the training set and 0.880 in the test set, together with favorable calibration and decision-curve performance. In the test set, both the vitamin-based model and the combined model outperformed the clinical baseline model (AUC 0.884 and 0.886 vs. 0.734; DeLong p < 0.001), whereas the combined model did not significantly improve over the vitamin-based model (ΔAUC = −0.005; p = 0.582).
Source: ResultsAbstract: Conclusion
This serum vitamin-related biomarker nomogram may assist early risk stratification for 3-month functional outcome after AIS. However, as this was a single-center retrospective study with internal validation only, the model should be regarded as preliminary and requires external multicenter validation and prospective evaluation of clinical impact in patient management and outcomes before routine clinical use.
Source: ConclusionAuthors’ abstract
Background
The prognostic value of vitamin-related biomarkers in acute ischemic stroke (AIS) remains incompletely defined. This study evaluated associations between serum vitamin-related markers and 3-month functional outcome and developed an internally validated nomogram for individualized risk prediction.
Methods
Consecutive AIS patients admitted to Huludao Central Hospital between November 2024 and July 2025 were retrospectively included (n = 655). The analyzed sample included 342 men (52.2%) and 313 women (47.8%), with a mean age of 66.84 ± 9.85 years and a mean admission NIHSS score of 3.98 ± 4.35. Poor outcome was defined as a 3-month modified Rankin Scale (mRS) score of 3 to 6, and good outcome as mRS ≤ 2. Demographic and clinical characteristics, routine laboratory indices, and serum levels of vitamin D, vitamin E, vitamin A, vitamin K1, vitamin B12, folate, and homocysteine were collected.
Candidate variables were screened by univariable analyses and entered into multivariable logistic regression. Multivariable analyses adjusted for age, sex, BMI, admission NIHSS score, infarct location, vascular risk factors, atrial fibrillation, coronary heart disease, moderate-to-severe arterial stenosis, serum albumin, and total protein. A nomogram was constructed using the rms package in R. Internal validation was performed with 1,000 bootstrap resamples. Discrimination, calibration, and clinical net benefit were assessed using receiver operating characteristic curves, calibration curves, and decision curve analysis.
Results
Among 655 patients, 346 (52.82%) had poor outcomes and 309 (47.18%) had good outcomes at 3 months. Multivariable analysis identified vitamin D, vitamin E, vitamin A, vitamin K1, vitamin B12, folate, and homocysteine as independent predictors of poor outcome. The nomogram showed good discrimination, with an AUC of 0.878 in the training set and 0.880 in the test set, together with favorable calibration and decision-curve performance. In the test set, both the vitamin-based model and the combined model outperformed the clinical baseline model (AUC 0.884 and 0.886 vs. 0.734; DeLong p < 0.001), whereas the combined model did not significantly improve over the vitamin-based model (ΔAUC = −0.005; p = 0.582).
Conclusion
This serum vitamin-related biomarker nomogram may assist early risk stratification for 3-month functional outcome after AIS. However, as this was a single-center retrospective study with internal validation only, the model should be regarded as preliminary and requires external multicenter validation and prospective evaluation of clinical impact in patient management and outcomes before routine clinical use.
Publication and source details
Original title: A vitamin-biomarker risk score for 90-day functional outcome after acute ischemic stroke: development and internal validation in a retrospective cohort
Yang Xu; Pengfei He; Xue Kang; Peihui Liu; Changming Xu
Frontiers in Neurology · 2026
* Correspondence: Peihui Liu, cmuliupeihui@gmail.com; Changming Xu, zxyyxcm_hld@163.comCopyright © 2026 Xu, He, Kang, Liu and Xu.2026Xu, He, Kang, Liu and Xuhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:24:42.323740+00:00
DOI: 10.3389/fneur.2026.1784930 · PMC13267819